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Investigation of Caenorhabditis elegans act-5 gene function revealed that intestinal microvillus formation requires a
specific actin isoform. ACT-5 is the most diverged of the five C. elegans actins, sharing only 93% identity with the other
four. Green fluorescent protein reporter and immunofluorescence analysis indicated that act-5 gene expression is limited
to microvillus-containing cells within the intestine and excretory systems and that ACT-5 is apically localized within
intestinal cells. Animals heterozygous for a dominant act-5 mutation looked clear and thin and grew slowly. Animals
homozygous for either the dominant act-5 mutation, or a recessive loss of function mutant, exhibited normal morphology
and intestinal cell polarity, but died during the first larval stage. Ultrastructural analysis revealed a complete loss of
intestinal microvilli in homozygous act-5 mutants. Forced expression of ACT-1 under the control of the act-5 promoter did
not rescue the lethality of the act-5 mutant. Together with immuno-electron microscopy experiments that indicated ACT-5
is enriched within microvilli themselves, these results suggest a microvillus-specific function for act-5, and further, they
raise the possibility that specific actins may be specialized for building microvilli and related structures.
INTRODUCTION
Actin proteins are fundamental structural components of
eukaryotic cells that mediate a wide array of cellular pro-
cesses (Pollard and Cooper, 1986; Herman, 1993). Actin is
required for cell polarization and division, organelle trans-
port and cell migration in addition to more specialized
cellular phenomena such as muscle contraction and ring
canal formation (Tilney et al., 1996). Most eukaryotes express
multiple actin proteins, each encoded by a distinct gene, but
these actin isoforms themselves share remarkable sequence
conservation, suggesting that common functional properties
have constrained their divergence during evolution. On the
other hand, many organisms express more than one actin
protein within the same cell, or differentially between cell
types, raising the possibility that nearly identical actins
evolved for specialized functions.
Gene rescue experiments in both Drosophila and mouse, in
addition to vertebrate overexpression studies, have indi-
cated that functional differences do indeed exist between at
least some actins within an organism (Schevzov et al., 1992;
Kumar et al., 1997; Fyrberg et al., 1998). However, the extent
to which the residues that distinguish isoforms confer func-
tional differences to the three-dimensional actin molecule,
and similarly, whether specific cellular structures use spe-
cific actin isoforms, is poorly understood.
The C. elegans genome encodes five actin genes. Whereas
ACT-1, -2, -3, and -4 all share 99% protein sequence identity,
ACT-5, the most divergent, shares 93% identity with the
others. Prior phenotypic analysis of animals that carry dom-
inant actin mutations affecting the act-1,2,3 gene cluster sug-
gest that these genes act primarily in muscle and myofila-
ment-containing cells (Waterston et al., 1984) and may exert
their dominance because of an altered rate or extent of
polymerization (Frieden et al., 2000). Moreover, molecular
analysis of revertants of the dominant actin mutations indi-
cate functional redundancy within this set of actins (Landel
et al., 1984). Although no dominant or recessive mutations
have been identified for act-4, transgene reporter studies
indicate that it, too, is predominantly expressed in muscle
cells (Stone and Shaw, 1993), although preliminary in situ
hybridization analysis with act-1, act-2, and act-4 probes
reveals more widespread expression of actin genes 1–4
(Shin-i and Kohara, 1998).
Here, we report a functional analysis of a single C. elegans
actin isoform, ACT-5. Genetic analysis led us to discover that
act-5 does not serve a muscle cell function nor does it encode
a general cytoplasmic actin. Instead, act-5 expression is lim-
ited to a subset of C. elegans somatic cells, all of which
contain microvilli or microvilli-like structures, and act-5
function is essential for the stable morphogenesis of intesti-
nal microvilli. Microvilli are actin-based cellular structures
that form plasma membrane projections into the extracellu-
lar space and whose specialized shape provides increased
cellular surface area. Microvilli are a crucial component of
the terminal differentiation process for many epithelial cell
types, usually ones that play an absorptive or filtering role.
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Although its function has long been recognized and appre-
ciated (Hirokawa and Heuser, 1981), the molecular mecha-
nisms that generate and stabilize a microvillus are poorly
understood. Actin filaments are known to be the core build-
ing blocks of microvilli, but whether a specific actin isoform
has evolved to be functionally specialized for this role has
not been demonstrated (but see Discussion; Sawtell et al.,
1988). The results presented here suggest that microvilli are
built, at least in part, by a specialized actin protein and that
in C. elegans, the ACT-5 isoform is uniquely adapted for this
function.
MATERIALS AND METHODS
Worm Strains and Plasmids
All strain backgrounds are Bristol N2. The following mutations were used:
IN700 dtEx418[pCKE1 (act-5::gfp), pRF4]; IN2054 dtIs419[pJAW70, pRF4]I;
IN2052 dtIs419(I);act-5 (dt2017)(III): IN2050 dtIs419[pJAW70, pRF4](I) act-5
(dt2019 dt2017)(III); IN2500 dtEx68[pRF4,pJJB8]; IN2501 dtEx69[pRF4,pJJB8];
IN2506 act-5(dt2017)III;dtEx68[pRF4,pJJB8]; IN2507 act-5(dt2017)III;dtEx69
[pRF4,pJJB8]; IN2502 dtEx70[pRF4,pJJB10]; IN2503 dtEx71[pRF4,pJJB10];
IN2505 dtEx75[pRF4,pJJB10].
A wild-type act-5() transgene, pJAW70, was made by amplification of C.
elegans genomic DNA with oligonucleotides 5-TGTTATTTTTAACTAGTG-
TAGAG-3 and 5-GTCCCAAGAATTGATCAATGACG-3. The amplification
product was digested with SpeI and BclI and cloned into pJAW72. pJAW72 is
a variant of the cloning vector pSL1180 in which the ApaI site was deleted.
Generation of the act-5 promoter-gfp transcriptional reporter pCKE1 used
two intermediate constructs, pNP2 and pNP4. pNP2 is identical to pJAW70
except the act-5 stop codon is mutated to an ApaI site. pNP4 is identical to
pNP2 except that a gfp cassette (derived from pPD95.69; kindly provided by
Andy Fire, Stanford University School of Medicine, Stanford, CA) was cloned
into the unique ApaI site of pNP2 to create a full-length act-5::gfp translational
fusion. pNP2 was modified by strand overlap extension (Ho et al., 1989) with
the following four primers: 5-TGTTATTTTTAACTAGTGTAGAG-3 paired
with 5-AATTTGAAAAAAAATCAGCGGGCCCGAAGCACTTTCGGTGA-
AC-3 and 5-GTCCCAAGAATTGATCAATGACG-3 paired with 5-GTTCAC-
CGAAAGTGCTTCGGGCCCGCTGATTTTTTTTCAAATT-3. The amplification
products of the first round reaction were then used as template for a second
round of amplification in combination with the outermost primers used in the
first round reactions. The resulting product was digested with SpeI and BclI and
cloned into pJAW72 to create pNP2. To make pNP4, An ApaI gfp coding region
cassette was produced by amplification of pPD95.69 (kindly provided by A. Fire)
with primers 5 GATCGGGCCCAGTAAAGGAGAAGAACTTTTC-3 and 5-
GATCGGGCCCTTATTTGTATAGTTCATCCATGCC-3, digested with ApaI,
and ligated into the unique ApaI site of pNP2. pCKE1 was derived from the
full-length act-5::gfp translational fusion by first linearizing pNP4 at the unique
SalI site in the act-5 coding region and then priming in opposite directions away
from the SalI site with primers 5-ACGTAGAGCTCAGTAAAGGAGAA-
GAACTTTTCACTG-3 and 5-CTAGCGAGCTCCATCTGAAATTAATA-
AAAGGTTGAAG-3. The primers create a synthetic SacI site (two amino acids)
in place of all but the initiator ATG of act-5 and maintain the reading frame with
downstream gfp cassette. The methylation-defective strain SCS110 (Stratagene,
La Jolla, CA), was used for all cloning procedures.
Gateway-based technology (Invitrogen) was used to drive expression of
either ACT-1 or ACT-5 cDNA open reading frames under the control of the
act-5 promotor. A Gateway destination vector was constructed using the
Gateway Vector Conversion System. Briefly, sequential QuikChange (Strat-
agene) reactions were carried out to add 5 and 3 SnaBI sites for blunt cutting
and ligation of the Gateway Reading Frame Cassette B into pCKE1 (replacing
GFP). The mutagenic primers used were 5-ACTCGTACATCACTTAATAACG-
TACGTATTTTCTATAAACTCGACTTCTTCAACC-3 and its complement and
5-GATGAACTATACAAATAGGGGCTACGTACCGCTGATTTTTTTTCAAA-
TTTTTTTTTTC-3 and its complement. After confirmation of QuikChange reac-
tions, Gateway Reading Frame Cassette B was ligated into the vector backbone,
replacing the sequence between the two constructed SnaBI sites; this vector was
named pJJB3.
pJJB8 (ACT-5 cDNA) and pJJB10 (ACT-1 cDNA), each flanked by act-5
regulatory regions were constructed by PCR amplification and recombination




GTGAACAATCG-3 and the ACT-5 cDNA clone cm19a6 as a template (Water-
ston et al., 1992). The ACT-1 open reading frame was amplified by reverse
transcription (RT)-PCR (Titan One Tube RT-PCR; Roche Diagnostics, Indianap-
olis, IN) by using the primers 5-GGGGACAAGTTTGTACAAAAAAGCAG-
GCTCAGGTACATTAAAAACTAATCAAAATGTGTGACGACGAGGTTGC-3
and 5-GGGGACCACTTTGTACAAGAAAGCTGGGTGTGCATTTAGAAG-
CACTTGCGGTGAACGATG-3 and total worm RNA as template. Each PCR
fragment was recombined into the intermediate entry clone pDONR201 by using
the Gateway BP clonase enzyme mix. The entry clones were then recombined
with pJJB3 by using the Gateway LR clonase enzyme mix and sequenced to
confirm that there were no unpredicted mutations.
PCR-based Screen and Identification of act-5 Deletion
Mutants
A PCR-based screening strategy was used to isolate the dt2017 allele from a
library of mutagenized C. elegans genomes, by using the following nested
primers: outer, CAGTTCTCCTTACCGAGGCTCC and AGTATCTCATG-
GAATTTGTGTC; and inner, AGTATCTCATGGAATTTGTGTC and GTGTT-
TCGCCTAGAAATGGAAG. dt2017 and dt2019 alleles contain a deletion be-
tween the coordinates 2535 and 2042 of cosmid T25C8; this deletion is flanked
directly by (5) TGTCACTCACACCGTTCCAA, (3) ACGTCGCCCACGACT-
TCGAG on the act-5 coding strand. dt2019 was derived from the dt2017 allele
and represents the sole mutation isolated among 250,000 mutagenized
haploid genomes that could suppress the starved appearance and slow
growth phenotype of IN2052 [pJAW70, pRf4] act-5 (dt2017) animals. In addi-
tion to the deletion described above, dt2019 contains a nonsense mutation
(G3A on the coding strand) at coordinate 2792 of cosmid T25C8.
Animals carrying dt2017 or dt2019 were identified by PCR-based molecular
typing with the following primers: CAGTTCTCCTTACCGAGGCTCC and
GTGTTTCGCCTAGAAATGGAAG (these primers amplify a 1268-base pair
product in wild type, and a shorter 774-base pair product if the deletion allele
is present). dt2017 heterozygous animals also could be identified based on
their relatively small, starved appearance. To identify the homozygote, het-
erozygotes were allowed to lay eggs over a period of 8 h; all F1 eggs were
counted and monitored throughout their development. After 2 d, all F1
progeny were lysed and individually assessed by PCR for the deletion or
wild-type act-5 sequence. Animals carrying act-5(dt2017) were backcrossed
more than 5 times before phenotypic analysis.
RNA Interference (RNAi)
Oligos 5-GTTAGTCTAGAACATGTGCCTTCCATTTCTAGGCG-3 and 5-
TCGGACTGCAGGAGAAAATGAAGTATCTCATGGAATTTG-3 were used
to amplify a region from the 3 untranslated region (UTR) of the act-5 mRNA
and flank it with synthetic XbaI and PstI sites. The 94-base pair PCR product
was cut with XbaI-PstI and cloned into the C. elegans feeding RNAi vector
pPD129.36 and transformed into HT115 cells (Timmons et al., 2001). RNAi
was performed as described previously (Kamath et al., 2001).
Mutant Rescue Assay
Because act-5(dt2107)/ animals grow slowly and act-5(dt2017) homozygotes
are inviable, transgenes can be used to test whether other worm actins can
substitute for ACT-5 in vivo. Rescue assays for ACT-5 or ACT-1 driven by the
act-5 regulatory regions were performed by first transforming wild-type
animals with either pJJB8 (ACT-5) or pJJB10 (ACT-1) and pRF4 as a coinjection
marker (Mello et al., 1991) to establish extrachromosomal array lines. Inde-
pendent transgenic lines were isolated by identification of F1 Rol progeny
(N  2 for pJJB8, N  3 for pJJB10). The transgenic lines were then crossed to
dt2017 heterozygotes to create dt2017/;Ex[pJJB8,pRF4] or dt2017/;
Ex[pJJB10,pRF4] strains. The genotypes were confirmed by PCR genotyping
(see below) to identify dt2017 heterozygotes and Rol progeny to identify the
presence of transgene. dt2107/ animals carrying the transgene were then
transferred individually to plates and allowed to reproduce at three intervals
for a total of 22 h to generate three relatively synchronized broods of F1
progeny. F1 embryos were counted and monitored for 48 h to determine
those that arrest relative to those that continue development beyond the L1
larval stage. Worms were then collected for genotyping, and their larval stage
recorded. Animals carrying dt2017 were identified by PCR-based molecular
typing with the following primers: CAGTTCTCCTTACCGAGGCTCC and
CTCATGTACTGAGAAATGTGAAGC (these primers amplify a 1027-base
pair product in wild type, and a shorter 533-base pair product if the deletion
allele is present). In all lines, we attempted to isolate homozygous dt2017
animals carrying the array as an indicator of rescue.
To confirm that ACT-1 cDNA array-carrying lines were expressing ACT-1
at the level of mRNA, we isolated total RNA from each independent trans-
genic line. RT-PCR (Titan One Tube RT-PCR; Roche Diagnostics) with the
following primers in all combinations was performed to confirm that the lines
carrying ACT-1 cDNA exhibited a new mRNA, corresponding to ACT-1
coding and ACT-5 3 UTR, that was not present in nonarray-carrying lines.
Primers used were ACT-1 coding 5-CTGATCGTATGCAGAAGGAAATC-3,
ACT-1 3UTR 5-GAAATAGAAAGCTGGTGGTGACGATGG-3, ACT-5 cod-
ing 5-GATCGTATGCAAAAGGAGATTCAAC-3, and ACT-5 3 UTR 5-
GAAGTATCTCATGGAATTTGTGTC-3.
Antibody Purification
Rabbit antisera raised against a synthetic ACT-5 peptide fragment (VAHD-
FESELAAA) was used to generate anti-ACT-5–enriched antibodies. The syn-
thetic peptide contained an artificial N-terminal cysteine and was coupled to
A. J. MacQueen et al.
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KLH as a carrier. Two cyanogen bromide-Sepharose columns (Sigma-Aldrich,
St. Louis, MO) were the basis of our affinity purification procedure: one
column contained coupled GST::ACT-5 (amino acids 167–322), whereas the
other column contained coupled GST::ACT-1 (amino acids 168–323). Gluta-
thione S-transferase (GST) fusions were expressed in Escherichia coli, isolated
from the insoluble fraction by using glutathione agarose, and visualized on a
Coomassie-stained protein gel (Smith and Johnson, 1988). ACT-1 and ACT-5
protein fusions (11.6 and 10.6 mg, respectively) were coupled to 3.5 ml of
resin. For purification, R7400 anti-ACT-5 antisera was passed through a
0.22-m filter and then loaded onto the GST::ACT-1 column. Flowthrough
was then loaded onto the GST::ACT-5 column. After several washes, bound
proteins were eluted using 0.1 M glycine, pH 2.5, and immediately neutral-
ized with 1/10 volume of 1 M Tris, pH 8. Purified antibodies strongly
recognized ACT-5::GST but only weakly bound to ACT-1::GST on Western
blots (our unpublished data).
Immunofluorescence and Light Microscopy
Wild-type embyros were collected in M9 buffer (22 mM KH2PO4, 22 mM
Na2HPO4, 85 mM NaCl, and 1 mM MgSO4) and bleached (Lewis and Flem-
ing, 1995) for 5 min with intermittent inversion. Samples were washed with
M9, followed by fixation in 3% formaldehyde (in 0.1 M sodium phosphate
buffer, pH 7.0, 0.1 mM EDTA) for 5 min. Embryos were transferred into
20°C methanol and stored at 20°C for up to 3 wk. For staining, samples
were flash frozen (in tubes) in liquid nitrogen and then thawed at room
temperature, twice. Samples were washed in 1 phosphate-buffered saline
(PBS) 0.001% Tween 20 (PBT) and then blocked for 2 h at room temperature
in 10% normal goat serum (Invitrogen) and 1% bovine serum albumin (BSA)
(fraction V; Roche Diagnostics) in PBT. After labeling (see below) samples
were stained with 0.1 g/ml 4,6-diamidino-2-phenylindole (DAPI) for 5 min
and mounted in 5% N-propyl gallate (Sigma-Aldrich) in 90% glycerol. Images
obtained through this staining procedure are suboptimal for labeling antigens
present in the embryonic intestine; however, the preparation conditions that
optimize for intestinal staining result in a loss of muscle actin antigens. The
method used maintains high levels of muscle actin C4 reactivity, while
allowing some antibodies to reach the intestine, providing a specificity com-
parison between anti-ACT-5 polyclonal antibodies and the pan-reactive
monoclonal antibody (mAb) C4.
L1 animals were collected in M9 buffer (act-5 mutants were picked between
20 and 36 h after egg laying, and wild-type L1 animals were collected by
allowing embryos to hatch overnight without food) before processing. For
MH33 and anti-actin staining, worms were fixed as described previously
(Ruvkun and Giusto, 1989) with modifications. In brief, worms were shaken
at 250 rpm in 0.3 ml of heptane, 0.1 ml of 90% methanol; 10% 0.1 M EGTA, 0.5
ml of 1 PBS, 0.08 M HEPES, 1.6 mM MgSO4, 0.8 mM EGTA, 3% formalde-
hyde for 30 at room temperature and then rapid-frozen in liquid nitrogen
followed by additional shaking for 1 h. Preparations were incubated for 12 h
in 5% 2-mercaptoethanol, 1% Triton X-100, 0.1 M Tris, pH 7.4, at 37°C, and
then they were rinsed three times in PBT, followed by a 1.75-h incubation at
37°C in 1 U/l collagenase VII (C0773; Sigma-Aldrich). After five washes in
PBT, samples were blocked for 1 h in 1% BSA (in PBT). For MH27 staining, L1
animals were processed as described previously (Finney and Ruvkun, 1990).
After labeling, samples were stained with 1 g/ml DAPI for 10 min and then
rinsed several times in PBT before mounting in 60% glycerol.
Primary antibody incubations were performed at room temperature over-
night; secondary antibody incubations were performed for 2 to 3 h at room
temperature. Antibodies and (dilutions) used were anti-ACT-5 (1:10); anti-
actin C4 (ICN) (1:100); MH33 (1:100); MH27 (1:100); Alexa 488 goat anti-
mouse and Alexa 568 goat anti-rabbit (Molecular Probes, Eugene, OR) (1:300).
MH33 and MH27 antisera were kindly provided by R. Frances and R. Wa-
terston (Washington University School of Medicine, St. Louis, MO).
Immunofluorescence preparations were examined using an Olympus
BMAX 60F microscope equipped with a Princeton Instruments KAF-1400
charge-coupled device camera, by using either a 60 (1.4 numerical aperture
[NA]) or 100 (1.35 NA) objective. Embryonic anti-actin, and L1 MH27
images were obtained using a Zeiss 510 META confocal microscope. Images
in Figures 2 and 6 were processed by a blind deconvolution algorithm, by
using the AutoDeblur software from AutoQuant.
Electron Microscopy
Animals grown for 2 d on act-5(RNAi) or control RNAi plates were collected
and processed for electron microscopy by high-pressure freezing followed by
freeze substitution (McDonald, 1999). A paste of diluted baker’s yeast was
used to gather 100 animals into one of each of five, 200-m specimen
carriers, and specimens were cryofixed in a high-pressure freezer (Leica
EMPact). Freeze substitution was carried out using a freeze substitution
machine (Leica AFS) as follows: samples were held in 2% osmium tetroxide,
0.1% uranyl acetate, and 8% dimethoxypropane in acetone at 78°C for 2 d;
warmed to –20°C 12 h; held at –20°C 12 h; and then warmed to 20°C 6 h.
Samples were rinsed six times in 100% acetone and infiltrated with Epon resin
as follows: 2:1 acetone:resin for 3 h, 1:1 acetone:resin overnight, 1:2 acetone:
resin 3 h followed by two changes in pure resin overnight. After embedding,
80-nm sections were cut onto Formvar grids and poststained in uranyl acetate
and lead citrate. Cross sections from 10 individuals were examined for act-5
and control RNAi animals.
L1 worms were collected in M9 buffer (see below) and prepared by chem-
ical/microwave fixation as described previously (Hall, 1995) with minor
modifications. Worms were placed in a prechilled ceramic dish on ice, with
prechilled fix (2.5% glutaraldehyde, 0.2 M sucrose, 1 mM MgCl2, 1% parafor-
maldehyde, and 0.05 M cacodylate buffer). Fixations were carried out on ice
with three, 2-min pulses in a temperature-controlled microwave (Pelco 3451
laboratory microwave system; Ted Pella, Redding, CA). Animals were rinsed
three times in 0.2 M cacodylate buffer and postfixed for 1 h in 1% osmium
tetroxide. After rinsing again in cocodylate buffer, animals were mounted in
2.5% agarose blocks and held at 4°C overnight. Blocks were stained with 1%
uranyl acetate, dehydrated with an increasing series of ethanol:water washes,
rinsed twice in propylene oxide, and then infiltrated with Epon resin gradu-
ally over the course of 2 d.
To obtain wild-type L1 animals, gravid adults were treated with bleach and
potassium hydroxide according to standard methods (Lewis, 1995) to isolate
several hundred eggs, and the eggs were hatched in S-Medium (Johnson et al.,
1984) solution overnight. To obtain a sufficient quantity of act-5 mutant L1
animals, 100 act-5(dt2017)/ gravid animals were placed on each of seven egg
collection plates, allowed to lay eggs for 8 h, and then removed. After 2 d, L1
arrested animals were manually picked into M9 buffer and immediately
processed as described above. Approximately 5000 wild-type and 500-1000
mutant L1 animals were processed. Cross sections of intestines from eight
mutant and eight wild-type animals were examined.
For immuno-electron microscopy, freeze substitution was carried out on
high-pressure frozen worm tissue as described in Bossinger et al. (2004),
except 0.1% uranyl acetate, instead of safranin O, was added to methanol for
the freeze substitution media. Samples were gradually infiltrated with LR
white resin over the course of 3 d and then embedded in gelatin capsules.
Sections (80 nm) were loaded onto nickel grids and processed for antibody
labeling, at room temperature, as follows: sections were rinsed in PBS and
then held 15 in 0.05 M glycine, 1 PBS, rinsed in PBS, and then held for 30
in blocking buffer (BB) (0.1% cold water fish gelatin, 0.8% BSA, 0.02% Tween
20, and 1 PBS. Samples were incubated in 15 l of primary antibody
(undiluted MH33 or anti-ACT-5; 1:50 anti-C4 actin antibody) for 1.5 h, rinsed
one time in BB and then twice in PBS, incubated in secondary antibody (1:50
5-nm gold-conjugated anti-mouse antibody or 10-nm gold-conjugated anti-
rabbit antibody; Amersham Biosciences, Piscataway, NJ) for 1.5 h. Samples
were rinsed 3  5 in PBS and postfixed in 0.5% glutaraldehyde, 1 PBS for
5. Grids were rinsed 3  5 in PBS and then twice in distilled water and
stained with uranyl acetate. All samples were analyzed using a JEOL 1200 EX
electron microscope operating at 80 kV.
Protein Extracts and Western Blotting
Total SDS-soluble nematode proteins were prepared as described previously
(Moerman et al., 1988) with the final extracts containing 0.18 g of packed
volume of worms per milliliter of solubilization buffer. Discontinuous 12%
SDS-polyacrylamide gels were used to separate 40 l of sample per well and
then blotted to nitrocellulose (Bio-Rad, Hercules, CA) in 25 mM Tris, pH 8.3,
192 mM glycine, and 20% (vol/vol) methanol. After blotting, the membrane
was probed with either a 1:2500 dilution of the C4 mouse anti-actin mAb, or
a 1:200 dilution of affinity-purified rabbit anti-ACT-5 in blocking buffer TTBS
[0.3 M NaCl, 20 mM Tris-HCl, pH 8.0, 0.1% (vol/vol) Tween 20, and 0.01%
NaN3 containing 5% BSA (wt/vol) and 5% (wt/vol) normal goat serum] for
6 h. Blots were washed four times in TTBS and then incubated for 2 h in
blocking buffer containing alkaline phosphatase-conjugated goat anti-mouse
(C4 blots) or goat anti-rabbit (anti-ACT-5 blots) antibodies from Pierce Chem-
ical (Rockford, IL). After four additional washes in TTBS, the blots were
developed for 1–10 min as described previously (Ey and Ashman, 1986). To
visualize the 38-kDa truncation product in act-5(dt2017)-carrying lines, the
blot must be developed for nearly 10 times longer than it takes to visualize the
full-length ACT-5 polypeptide (Supplemental Figure 1).
RESULTS
act-5 Is Expressed in Cells That Contain Microvilli
Analysis of a reporter transgene revealed that act-5 expres-
sion is restricted to a small subset of cells within the C.
elegans alimentary tract and excretory systems. A transgene
construct containing GFP (gfp) (Chalfie et al., 1994), flanked
upstream and downstream by roughly 1.5 kb of T25C8.2
regulatory sequence (pCKE1; see Materials and Methods), was
heritably transformed into wild-type animals. GFP fluores-
cence was easily detected within a subset of embryonic,
larval, and adult cells in transgenic animals, consistent with
previous findings on the act-5 expression pattern (Figure 1;
Gobel et al., 2004). Within larvae and adults, GFP expression
occurred within the 20 cells that comprise the adult intestine,
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and in two sets of three associated cells: one just anterior and
one posterior to the intestine. The anterior set corresponds to
the middle of three sets of pharyngeal-intestinal valve cells
(vpi 2), whereas the posterior group of associated cells
comprises the rectal epithelial cell (rectD, rect_VL, rect_VR)
(Sulston et al., 1983). Finally, the single excretory canal cell,
which extends processes along the entire length of the
worm, also showed GFP expression. The aforementioned
act-5-expressing cells derive from three separate embryonic
founder cell lineages yet, interestingly, each belongs to the
small number of cells reported to contain microvilli or canal-
iculi (microvilli-like processes that increase the lumenal sur-
face area of the excretory canal cells) in C. elegans (Sulston et
al., 1983; Buechner, 2002).
Anti-ACT-5-enriched Antibodies Label the Apical Domain
of Polarized Intestinal Cells
The level of shared identity between actin proteins makes
immunolocalization of specific isoforms challenging (Her-
man, 1993). To create antibodies that label ACT-5 with min-
imal cross-reactivity to other C. elegans actins, we performed
a two-step affinity purification procedure on polyclonal an-
tisera, which was generated using a divergent 13-amino acid
stretch within ACT-5 (see Materials and Methods). Both initial
and purified anti-ACT-5 antisera recognized a major 43-kDa
band on protein blots of wild-type animals (Supplemental
Figure 1; our unpublished data).
Evidence that the purified antibodies are significantly en-
riched for anti-ACT-5 activity came from immunolabeling
experiments on fixed C. elegans embryos (Figure 2, a–d).
Whereas a pan-reactive anti-actin antibody labeled numer-
ous cell types, including prominent staining of the four body
wall muscle quadrants that run the length of the worm,
anti-ACT-5 enriched antisera showed robust label only in
the small subset of embryonic cells that belong to the intes-
tine, accompanied by an extremely low level of staining in
muscle cells.
Anti-ACT-5 immunolabeling further indicated that ACT-5
is apically localized within intestinal cells. An apical subcel-
lular localization pattern of ACT-5 within the intestine is
consistent with previous studies that exploited a yellow
fluorescent protein (YFP)::ACT-5 or GFP::ACT-5 transla-
tional fusion protein expressed from a transgene (Bossinger
et al., 2004; Gobel et al., 2004). Analysis of larval and adult
animals labeled with anti-ACT-5 revealed robust, continu-
ous antibody localization along the length of the intestine
immediately adjacent to the lumenal surface, whereas al-
most no label could be detected in cytoplasmic and basal
regions of intestinal cells (Figure 2, e and f; Bossinger et al.,
2004; Gobel et al., 2004). In contrast to the act-5::GFP tran-
scriptional reporter, no antibody staining of the excretory
cell was observed. The latter could be due to the stringent
extraction procedures that are required to optimize immu-
novisualization of ACT-5 in the gut, or the much lower level
of ACT-5 expression in the excretory cell relative to the gut.
It is noteworthy that the pan-reactive mAb C4 also does not
reveal the actin within the excretory cell using the whole
mount fixation methods used for these studies. An apical
subcellular localization of ACT-5 within the intestine is in-
triguing in light of the fact that act-5 expression is limited to
cells containing microvilli and suggests the possibility that
act-5 might play a role in microvillus formation or function.
act-5(RNAi) Causes a Reversible Defect in Intestinal
Lumen Morphogenesis
Previous studies implicated a functional role for act-5 in
intestinal lumen morphogenesis (Gobel et al., 2004). RNAi
directed at the 3 UTR of act-5 produces low-penetrance
lumenal phenotypes that mimic those caused by a mutation
in erm-1, a gene that encodes an actin-binding protein that is
required for proper intestinal lumen morphogenesis (Gobel
et al., 2004). act-5(RNAi) also causes a significant amount of
L1 arrest and lethality (Gobel et al., 2004). Using a feeding
RNAi strategy (Kamath et al., 2001; Timmons et al., 2001), we
observed the same constellation of act-5(RNAi) phenotypes
as those described previously (Gobel et al., 2004), with one
important addition; act-5(RNAi) is reversible. When several
animals, belonging to the most extreme growth-arrested
class, were removed to standard bacteria plates after 72 h of
development on act-5(RNAi) plates, about one-half of the
Figure 1. Excretory and alimentary tract
cells express act-5. (a and b) GFP expression,
controlled by act-5 promoter sequences, is
observed within each of the 20 pairs of in-
testinal cells that form a tube along most of
the length of the animal; the H-shaped ex-
cretory cell (EC), pharyngeal-intestinal valve
cells (VPI), and rectal epithelial cells (REP)
also express the transgene reporter. The
act-5::gfp transgene has been lost from intes-
tinal cells of the animal in b, allowing better
visualization of the EC, REP, and VPI cells.
Anterior is left.
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animals (10/18) grew into reproductive adults within the
next 3 d. The reversibility of act-5(RNAi) indicates that the
process affected by act-5 depletion is ongoing throughout
larval growth, rather than a discrete embryonic develop-
mental event. Together with the expression pattern and
subcellular localization of act-5, the phenotypic effects of
act-5(RNAi) suggest the possibility that act-5 function is re-
quired for proper morphogenesis of the intestinal lumenal
surface (Gobel et al., 2004).
act-5 Function Is Dispensable for Embryogenesis but
Essential for Larval Growth
To more rigorously address the developmental requirement
for act-5 function, we carried out a molecular genetic screen
for act-5 mutants. We used a PCR-based strategy to screen a
frozen mutant bank representing 1 million mutagenized
haploid genomes (kindly provided by V. Reinke, Yale Uni-
versity, New Haven, CT). This effort identified act-5 (dt2017),
which contains a 494-base pair deletion within T25C8.2.
dt2017 is predicted to encode a protein that has replaced 54
central amino acids (residues 166–219 of ACT-5) with a
single asparagine residue (Figure 3). The portion deleted
from the dt2017 gene product normally spans parts of both
subdomains 3 and 4 of the three-dimensional actin molecule,
and moreover, includes residues thought to be important for
ATP/ADP binding (Pollard and Cooper, 1986; Kabsch and
Vandekerckhove, 1992; Herman, 1993). The extent of the
lesion, in light of the fact that actins have diverged so little
during eukaryotic evolution, indicates that the putative pro-
tein product of the dt2017 deletion allele has lost actin func-
tion. A second allele, act-5 (dt2019), which is derived from
dt2017 (see Materials and Methods), additionally contains a
premature stop codon upstream of the dt2017 deletion. The
dt2019 allele thus encodes a 78-amino acid peptide fragment
of the 375 residue ACT-5 protein and is also almost certainly
a null allele for a conventional actin such as ACT-5 (Figure
3).
Observation of the growth of all individuals within a
brood from dt2017 heterozygotes revealed a class of progeny
that move slowly, exhibit slowed or nonexistent pharyngeal
pumping, and die, as early L1 larvae, within 2 to 3 d after
hatching. Scoring each animal within this brood for both
growth rate and genotype demonstrated that the L1 lethal
class corresponds to act-5 homozygotes (Figure 4a). This
analysis further revealed that act-5 (dt2017) heterozygotes
have a slightly slower growth rate than wild-type animals,
Figure 2. anti-ACT-5 specifically labels the
apical intestine. (a–d) Wild-type embryos
costained with purified anti-ACT-5 antibod-
ies (a and b) and C4, a pan-reactive anti-actin
mAb (c and d). Images represent single con-
focal optical sections from the middle third
(a and c) and top third (b and d) of the same
threefold embryo. Arrows indicate the pos-
terior (a and c) and anterior (b and d) of the
intestine, where robust anti-ACT-5 label, but
very little C4 staining is present (a vs. c);
arrowheads point to a single longitudinal
body wall muscle quadrant, which is not
detected with anti-ACT-5 but readily labeled
with C4 (b vs. d). Bar, 5 m (a–d). (e and f)
Wild-type L1 animals stained with anti-
ACT-5, in white (e) or red (f); DAPI-stained
nuclei are shown in blue (f). ACT-5 label
decorates the lumenal surface of the intes-
tine, showing as a tube along most of the
length of this L1 animal. Images in e and f
are projections of serial image slices that en-
compass approximately one-half the volume
of an intestine and derive from the central
portion of the intestine; this processing re-
veals the unlabeled lumenal area at the cen-
ter of the intestine. Bar, 10 m (e and f).
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accompanied by a smaller size and clear appearance, remi-
niscent of act-5(RNAi) animals (Figure 4b). dt2017 heterozy-
gotes do, however, reach adulthood and are fertile. The
dt2017 heterozygote phenotype raised the possibility that
dt2017 has dominant negative activity, or alternatively, that
act-5 is a rare haploinsufficient locus in C. elegans.
A transgene rescue experiment confirmed that the L1
lethal phenotype associated with act-5 mutations is indeed a
consequence of missing act-5 function. The lethality associ-
ated with either act-5 allele is completely suppressed in
transgenic worms carrying pJAW70, which contains roughly
3 kb of genomic flanking sequence accompanying a wild-
type act-5 gene. However, although the L1 lethality of act-
5(dt2017) homozygotes was rescued by pJAW70 carried ei-
ther as an extrachromosomal or integrated transgene, these
animals still looked clear and smaller than wild-type ani-
mals, similar to dt2017 heterozygotes. This phenotype is
dependent on the dt2017 allele, as pJAW70-carrying animals
that are wild-type at the act-5 locus are normal in size and
appearance. The failure of act-5 () to suppress the pheno-
typic effects of one copy of the dt2017 allele argues against
haploinsufficiency as the basis for dominance and is more
consistent with the dt2017 gene product having dominant
negative activity. Consistent with this hypothesis, protein
extracts from animals that are dt2017 homozygotes but carry
a wild-type act-5() transgene show accumulation of an
38-kDa product that is absent in wild-type worms that
carry the integrated act-5() transgene (Supplemental Fig-
ure 1).
Further support for the notion that dt2017 is a dominant-
negative allele comes from the fact the act-5 (dt2019) muta-
tion, which contains a premature stop codon that predicts
production of a significantly smaller mutant derivative of
actin than the dt2017 product, was isolated as a suppressor
of the slow growth and starved appearance of pJAW70-
carrying, dt2017 homozygotes. At the level of the dissection
microscope, animals homozygous for either dt2017 or dt2019
are indistinguishable and die as young L1 larvae. Moreover,
dt2019 is by all apparent criteria, completely recessive.
act-5 Mutant Intestinal Cells Undergo Cell Division,
Gastrulation, and Are Properly Polarized
Although actin often functions in basic cellular processes
that are essential for cell polarity, cytokinesis, and viability,
intestinal cells in act-5 mutants form a grossly normal and
intact organ comprised of viable, correctly positioned, and
properly polarized cells. First, using Nomarski differential
interference contrast microscopy, we did not observe any
obvious disruption along the length of act-5 mutant L1 ani-
mals that might indicate a developmental defect in intestinal
morphogenesis, although, due to the small size and un-
healthy appearance of act-5 mutant L1 animals, a completely
continuous lumen was difficult to trace by using this
method. Immunolocalization of actin, IFB-2 (the gut-specific
Figure 3. Actin protein alignment and sequence changes caused by act-5 mutations. C. elegans actin protein alignment. ClustalW 1.83
alignment (Thompson et al., 1994) between the five C. elegans actins (CeACT-1–5, accession nos. CAB04678, CAB04675, CAB04676, AAB04575,
and CAB05817, respectively) and the predicted Caenorhabditis briggsae ACT-5 (CbACT-5, accession no. CAE71353). The protein sequence for
C. elegans ACT-1 and ACT-3 are identical and denoted as CeACT-1_3. Identical residues are shaded in black, conserved changes in gray.
Sequence coordinates are given for the entire alignment, which is offset 1 residue for CeACT-5 and CbACT-5. The boxed region at residues
220–232 indicates the synthetic peptide used to elicit anti-ACT-5 antibodies. Asterisk indicates the position of the premature stop codon in
dt2019; down arrows denote the region deleted in dt2017 and replaced by asparagine.
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intermediate filament protein recognized by MH33 mAb;
Francis and Waterston, 1991; Bossinger et al., 2004), or the
adherens junction marker JAM-1 (recognized by MH27
mAb; Francis and Waterston, 1991; Legouis et al., 2000; Ko-
ppen et al., 2001) confirmed that act-5 mutants have com-
pletely elaborated intestines with lumens that are continu-
ous along their length (Figure 5; our unpublished data).
Intestinal cells maintain different molecular and func-
tional microenvironments between apical and basal regions
(Legouis et al., 2000). In C. elegans, MH27 mAb highlights
this epithelial cell polarity, because it specifically labels junc-
tions between the apical regions of cells (Leung et al., 1999).
The polarized distribution of the MH27 antigen within the
intestine looks like two narrow linear axes running imme-
diately adjacent to and along the length of the intestinal
lumen, bridged at specific locations throughout their lengths
by perpendicular-oriented axes (Figure 5). In act-5 mutants,
MH27 is clearly restricted to regions along the length of the
narrow intestinal lumen, demonstrating that act-5 function is
dispensable for establishing apical-basal polarity within in-
testinal cells. Further support for this conclusion was pro-
vided by ultrastructural analysis (see below), because apical
junctions were observed exclusively associated with the lu-
menal side of act-5 mutant intestinal cells. The MH27 distri-
bution pattern was found to be somewhat distorted in act-5
mutants relative to wild-type animals, which may reflect a
requirement for act-5 in forming normal apical junction
structures. Alternatively, this distortion might reflect the fact
that act-5 animals are more vulnerable to damage during the
immuno-fixation and processing procedure, because they
normally die as L1 animals, shortly after hatching.
act-5 Is Essential for Gut Microvillus Formation
Although the L1 lethality associated with mutations in act-5
could reflect a defect in any of a number of actin-dependent
processes, the act-5(RNAi) phenotypes together with the
subcellular localization of ACT-5 hinted at a possible role for
this gene product in microvillus formation or function. To
ask whether act-5 is involved in microvillus morphogenesis,
we analyzed the ultrastructure of intestinal cells from wild-
type and act-5 mutant L1 animals by using transmission
electron microscopy. Several consecutive cross sections of
intestines from seven or more wild-type and mutant animals
were analyzed. In wild-type cross-sections prepared by
chemical/microwave fixation, microvilli looked like broad
finger-like projections reaching into an oblong intestinal lu-
men (Figure 6). Two apical junctions, located roughly equi-
distant from one another along the circumference of the
lumen, were apparent as microvilli-like structures but their
orientation was pointed away from the lumen (Figure 6,
arrowheads). The terminal web was notable in wild-type
sections as a continuous, electron-dense border at the base of
Figure 4. act-5 is essential for growth. (a) Table presents an analysis of the growth of individual animals in a brood, after 2 d. Animals were
assayed by PCR to identify genotype after their phenotype was recorded. act-5 (dt2017) homozygotes correspond to animals that fail to grow
beyond the first larval stage (L1), even after 2 d of development. (b) Adults carrying one copy of act-5 (dt2017) are skinny and clear (right),
compared with wild-type adults (left). Images were taken with bright field optics.
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microvilli and along the circumference of the intestinal lu-
men. In contrast to wild type, intestinal cross sections from
act-5 mutants contained lumens that were frequently round
instead of oblong, and often, but not always, associated with
an abnormally thick terminal web structure. The circumfer-
ence of the lumen itself did not significantly differ between
wild-type and mutant animals. Furthermore, the apical junc-
tions that accompany act-5 mutant intestinal cells often
seemed abnormally lengthened, although to varying extents
from section to section. Most striking, however, was the
complete absence of microvilli within the lumens of act-5
mutant intestines (Figure 6B). Out of five cross sections
analyzed from each of seven animals, no microvilli were
detected in act-5 mutant intestines, whereas microvilli were
always readily visible in wild-type intestinal cross sections.
Defects in the ultrastructural appearance of intestines
from growth-retarded, act-5(RNAi) animals were less obvi-
ous than those for dt2017 animals; however, one-half of
analyzed cross sections (n  20) exhibited unequal apical
surface lengths between the two cells comprising a given
section of the lumen, accompanied by an abnormally thick
terminal web associated with the shorter apical surface (Fig-
ure 6D). Distorted and elongated apical junction structures,
and/or regions with severely disrupted or missing mi-
crovilli also were exhibited by a subset of sections, especially
among those sections exhibiting abnormally short apical
regions. The relatively mild severity of the defects exhibited
by act-5(RNAi) intestinal cross-sections is consistent with the
fact that act-5(RNAi) elicits a weaker phenotype compared
with that of act-5 loss-of-function genetic mutants.
ACT-5–enriched Antibodies Predominantly Label
Microvilli in Thin Sections
To begin to ask whether a specialized actin isoform could be
responsible for building microvilli in the C. elegans intestine,
we analyzed the distribution pattern of the ACT-5–enriched
antisera on cross sections of wild-type adult worms. We
labeled consecutive sections with either MH33 antisera,
which detects intermediate filaments, or a pan-reactive anti-
actin antibody (C4) to control for the success of our tech-
nique. Additional sections were incubated with secondary
antibody only, to assess nonspecific background labeling. As
has been reported previously (Bossinger et al., 2004), MH33
antisera decorated the terminal web and apical junction
structures, with little or no detectable label in other regions
of the cross section (Figure 7, b and c). The pan-reactive
anti-actin antibody displayed some labeling throughout the
terminal web, apical junctions, and along the length of mi-
crovilli (Figure 7d). Anti-actin label also decorated other
regions of the section, such as areas containing muscle cells
(Figure 7e). In contrast to either MH33 or C4 anti-actin
antibody, the anti-ACT-5–enriched antibodies exhibited ro-
bust label along the lengths of microvilli, sparse labeling at
the terminal web, and no above-background label in other
regions of the sections, most notably those containing mus-
cle cells (Figure 7, a–c, and f). This distribution pattern is
exactly what one would predict for a building block com-
ponent of microvilli, and as such it provides strong evidence
that act-5 encodes a major actin component of microvilli.
The ACT-5 Protein Isoform Is Uniquely Adapted for the
Essential act-5 Function
The requirement for wild-type act-5() gene function for
microvillus biogenesis and viability could be at the level of
gene expression or protein isoform specialization. Previous
work on the Act5C gene of Drosophila showed that the
inviability associated with the loss of this essential gene
could be rescued by a chimeric transgene in which the Act5C
regulatory sequences drive expression of the closely related
Drosophila actin, Act42A (Wagner et al., 2002). In this case,
the unique temporal and quantitative regulation of actin
levels, dictated by the Act5C promoter, served the essential
Figure 5. Intestinal cell polarization does
not require act-5 function. MH27 staining
(white) labels apical regions of polarized
cells, giving rise to a web-like pattern along
the bodies of the wild-type (left) and act-
5(dt2017) mutant (right) worms. Although
act-5 mutant intestinal lumens seem slightly
deformed relative to control animals, MH27
is properly restricted to apical cell regions in
both genotypes. Projections encompass the
entire volume of each animal. Anterior (ant.)
and posterior (post.) ends of the worm are
indicated. Bar, 10 m.
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Figure 6. Intestinal microvilli are defective or absent from ACT-5–depleted animals. In wild-type ultrastructural preparations (a and c),
intestinal cross sections reveal tightly packed, finger-like projections that correspond to microvilli projecting from the lumenal surface. At the
base of these projections is an electron-dense region called the terminal web (TW). A small segment of the terminal web is enclosed by
brackets in a and b. Two finger-like projections pointing toward the cytoplasmic side of the intestinal cells are the apical junctions
(arrowheads) that mark the boundary between apical regions of two intestinal cells. Microvilli are absent from intestinal cross sections of act-5
(dt2017) animals (b). act-5(RNAi) animals frequently exhibited one shortened apical region (distance between apical junctions) on one of a pair
of intestinal cells; this shortened apical surface was typically associated with an abnormally thick terminal web (d). Equivalent higher
magnification views of a portion of the thick (e) and normal terminal web width (f) from the micrograph shown in d reveal the difference
in thickness as the gap between the arrows (e and f). Control RNAi cross section from an L2–L3 stage animal shown in c. Bar for a and b in
b; for c and d in d, 500 nm.
ACT-5 Is Required for Gut Microvilli
Vol. 16, July 2005 3255
function, rather than the distinct amino acid differences of
Act5C relative to Act42A. Considering this precedent, it is
possible that in C. elegans, the act-5 regulatory sequences
may simply produce gut actin levels that reach a critical
temporal or quantitative threshold optimized for the biogen-
esis of microvilli and that any of the other four highly related
worm actins, 99% identical to each other and 93% identical
to ACT-5, could serve the essential functions of the ACT-5
protein if expressed under the control of the act-5 regulatory
sequences. To address this possibility, we chose ACT-1,
which is 100% identical to ACT-3 and 99% identical to
ACT-2,4, as a representative of the non-ACT-5 actins, and
drove the expression of the ACT-1 cDNA under the control
of the act-5 regulatory sequences (Pact-5::ACT-1). Because
the Pact-5::ACT-1 construct lacks introns relative to the
genomic act-5 construct, we generated the analogous con-
struct with the ACT-5 cDNA (Pact-5::ACT-5) as a positive
control for comparison. Suitable transgenic lines were made
by microinjection and then these transgenes were crossed
with the dominant dt2017/ animals to obtain animals with
genotypes dt2017/;Pact-5::ACT-1 or dt2017/;Pact-5::ACT-5.
F1 progeny from the transgenic dt2017/ adults were scored
Table 1. Actin isoform-specific rescue of act-5(dt2017)
Transgene Stage (N)
Genotype
dt2017/dt2017 dt2017/ / % Rescuea
Pact-5::ACT-5 L1 (3) 3 0 0 76
L2 (92) 10 57 25
Pact-5::ACT-1 L1 (33) 33 0 0 0
L2 (167) 0 103 64
Shown are data for rescue assays performed on independent lines carrying an extrachromasomal transgene expressing either ACT-5 (2
independent lines) or ACT-1 (3 independent lines) both under the control of act-5 5 and 3 regulatory sequences. Rescue assays measured
the developmental stage and genotype of multiple individual progeny of dt2017/, transgene-carrying hermaphrodites 48 h after egg
laying.
a Percentage of rescue is defined as the number of dt2017 homozygotes that grow beyond the L1 stage after 48 h.
Figure 7. anti-ACT-5 antisera labels microvilli on thin sections. Gold particles (10 nm), detecting anti-ACT-5 antisera, exhibit robust labeling
on microvilli of wild-type intestinal cross sections (a–c), whereas exhibiting little or no label in other areas of the section (muscle cells in f).
MH33 antisera, marked by 5-nm gold particles, labels the terminal web and apical junction areas (b and c). C4 (marked by 5-nm gold
particles), a pan-reactive monoclonal anti-actin antibody, which detects several, if not all, C. elegans actins, labels microvilli (d) in addition
to several additional cells within the worm; muscle cell labeling is shown in e. Insets in b, c, and d show enlarged regions to enable better
visualization of 5-nm gold particles. Bar, 500 nm.
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for L1 arrest versus continuous development and to assay
whether rescued dt2017 homozygotes could be recovered.
Table 1 compares the genotype of the progeny and their
developmental stage for the Pact-5::ACT-5 and Pact-5::ACT-1
transgenic lines. The genotyping data clearly indicate that
although the Pact-5::ACT-5 transgene rescued 76% of the
dt2017 homozygotes, all of the dt2017 homozygotes in the
Pact-5::ACT-1 transgenic line arrest as L1 larvae (Table 1).
Moreover, the dt2017; Pact-5::ACT-5 animals are easy to es-
tablish as stable, heritable strains. These rescue data are most
consistent with the ACT-5 isoform having unique properties
that are adapted to its specialized function in microvilli or
other structures required for viability.
DISCUSSION
A Functional Link between a Divergent Actin and
Microvillus Formation
We provide genetic evidence that implicates a distinct C.
elegans actin isoform in microvillus morphogenesis. Further-
more, our immunocytological analysis revealed that ACT-5
is specifically expressed and apically enriched within mi-
crovilli-containing cells of the intestine, and ultrastructural
analysis indicated that ACT-5 is likely located within mi-
crovilli themselves. Together, our findings and previous
work on the distribution of YFP-ACT-5 (Bossinger et al.,
2004) and the phenotype induced by act-5(RNAi) (Gobel et
al., 2004) strongly suggest that ACT-5 may directly serve as
a core building block for microvillus formation.
Whereas the function and ultrastructure of microvilli have
been appreciated for decades (Hirokawa and Heuser, 1981),
the molecular pathways that underlie their initial formation
and stabilization have remained elusive. This could, in part,
be due to the fact that genes required for microvilli forma-
tion also likely serve additional essential functions. Muta-
tions in such loci might thus exhibit severe defects that
precede or preclude an ability to examine microvillus for-
mation. eps-8 is an excellent example of a gene required for
early embryonic development but that also has later func-
tions in the intestine (Croce et al., 2004). EPS-8 is a C. elegans
orthologue of a receptor tyrosine kinase substrate that has
barbed-end actin capping activity and is widely expressed
and enriched at the apical tip of microvilli (Croce et al., 2004;
Disanza et al., 2004). eps-8 is essential for embryonic devel-
opment but produces two isoforms, EPS-8A and EPS-8B
(Croce et al., 2004). An EPS-8A–specific knockout permits
normal embryonic development but animals arrest as L1-L2
larvae with major defects in the gut, and the mutant can be
rescued by intestine-specific expression of EPS-8A (Croce et
al., 2004). Given that EPS-8A is uniquely adapted among
EPS-8 isoforms to serve an essential function in the gut, it is
reasonable to suggest that specific actin isoforms also might
be uniquely adapted to the microvillus-specialized actin-
binding proteins.
Larval Lethality and act-5 Function
The experiments reported here show that act-5 loss-of-func-
tion mutations result in early larval lethality. An absence of
microvilli is expected to result in severely diminished intes-
tinal absorption, but starvation per se is typically not asso-
ciated with L1 lethality since a “checkpoint” pathway, which
arrests the growth of wild-type L1 animals, can be triggered
during absolute starvation conditions. Because of this check-
point, starvation-arrested L1 larvae can live at least 10 d in
the absence of food (Johnson et al., 1984), whereas act-5
mutants lived no longer than 72 h.
Perhaps through its role in building proper microvilli,
act-5 is required for execution of the L1 starvation arrest
pathway. In particular, one could imagine that proteins on
the surface of microvilli themselves might monitor nutrient
absorption and/or food availability, and thus serve as an
essential component of the initiating signals that trigger
starvation arrest. Alternatively, act-5 function might be re-
quired for apical surface remodeling that perhaps needs to
occur within the intestines of L1 animals for survival during
starvation conditions. Finally, a high surface area intestine
might be required for efficient elimination of feces or meta-
bolic waste generated by the organism, regardless of food
supply status.
Another potential explanation for L1 lethality is that act-5
animals are on one or the other side of a critical threshold of
nutrient deprivation that is required for starvation arrest to
be elicited. On the one hand, act-5 mutants might absorb
enough food to prevent starvation arrest but an insufficient
amount to nourish proper growth. On the other hand, per-
haps an absence of microvilli leads to irreparable damage
during late embryonic stages, before the worm has the ca-
pacity to trigger the starvation arrest checkpoint pathway,
the latter of which presumably occurs after hatching.
Finally, rather than lethality due to loss of intestinal mi-
crovilli, L1 lethality might reflect an essential function for
act-5 in the excretory cell, which is thought to control osmo-
regulation (Nelson and Riddle, 1984). It will be interesting to
explore this possibility by assessing whether L1 lethality of
act-5 mutants can be rescued by a wild-type act-5 transgene
expressed exclusively within the excretory cell, the intestine,
or other cell types, even those for which we have not yet
detected expression of ACT-5.
ACT-5 Is Uniquely Specialized for Microvilli Formation
Suggestion of the existence of a microvillus-specific actin in
vertebrates was provided over a decade ago by analyses of
isoform-restricted antibodies on rat intestinal epithelia (Saw-
tell et al., 1988). Here, we provide the first genetic evidence
in support of the notion that a specialized actin functions in
microvilli biogenesis. How, at the molecular level, might
act-5 be unique among C. elegans actins in participating in
microvilli morphogenesis?
One possibility is that act-5 function is required for mi-
crovilli formation simply because it is the sole actin ex-
pressed in intestinal cells. Two observations in this study
strongly argue against this possibility. First, a scenario in
which act-5 encodes the only actin in intestinal cells is not
compatible with the terminal phenotype of act-5 loss-of-
function mutants because embryonic intestinal cells are
competent to grow, divide, and terminally differentiate into
polarized epithelia in these animals. Second, and more im-
portantly, expression of ACT-1 under the control of the
ACT-5 promoter does not rescue the inviability of dt2017
mutants. Based on our data, protein sequence differences
between ACT-5 and the other C. elegans actins most likely
render ACT-5 functionally distinct and specialized for mi-
crovilli formation or an unknown essential function.
Evidence for functional differences among actin isoforms
also has been found in Drosophila, where a cytoplasmic actin
failed to rescue the flight defect caused by a muscle actin
mutation, and in mammals, where a mouse lacking cardiac
muscle actin could not be rescued by cardiac expression of
an endogenous but noncardiac muscle actin protein (Kumar
et al., 1997; Fyrberg et al., 1998). Similarly, overexpression
studies in vertebrate cultured cells support the notion that
some actin isoforms exhibit distinct functional capacities
(Schevzov et al., 1992). Finally, point mutations in the human
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ACTG1  actin isoform have been implicated as the caus-
ative defect in autosomal dominant, progressive hearing loss
in humans (van Wijk et al., 2003). Given that the stereocilia of
the inner ear contain numerous microvilli-like structures
whose characteristic staircase organization and length prob-
ably play a central role in hearing (Hudspeth and Jacobs,
1979; Howard and Hudspeth, 1987), and the potential for
microvilli-specialized actins described here, it is possible
that ACTG1 is uniquely adapted for function in the mi-
crovilli of the inner ear.
Future exploration of the molecular relationship between
act-5 function and microvilli morphogenesis by using C.
elegans promises to shed new light on the mechanisms un-
derlying both actin functional diversity and the biogenesis
of microvilli in the gut and other tissues that exploit mi-
crovilli for specific physiological needs.
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